Question 86

Lokelma is indicated to treat hyperkalemia.

Lokelma is specifically designed to treat hyperkalemia, which is an elevated level of potassium in the blood. It works by binding potassium in the gastrointestinal tract, thereby reducing its absorption and helping to lower potassium levels.

A) Levoxyl

Levoxyl is a synthetic form of thyroxine (T4) used primarily to treat hypothyroidism. It has no role in the management of hyperkalemia and would not be effective in treating elevated potassium levels.

B) Loperamide

Loperamide is an anti-diarrheal medication that works by slowing down gut movement. It does not address potassium levels in the body and is therefore ineffective in treating hyperkalemia.

C) Levetiracetam

Levetiracetam is an anticonvulsant used to treat seizures. While it is important for managing neurological conditions, it does not have any indication for the treatment of hyperkalemia.

D) Lokelma

Lokelma is specifically indicated for the treatment of hyperkalemia. It functions by trapping potassium in the intestine, which helps to lower serum potassium levels effectively.

Conclusion

Lokelma is the only medication among the options provided that is specifically indicated for the treatment of hyperkalemia. The other options—Levoxyl, Loperamide, and Levetiracetam—are not related to potassium management and thus do not address the condition. This distinction reinforces Lokelma's essential role in treating elevated potassium levels effectively.